Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ronran - RE: mvaar...

ronran - RE: mvaar...

posted on Feb 14, 2006 09:48AM
The fact that Pohl didn`t stipulate this as a ``one-time`` dividend leaves the door open for this to continue.

Also perhaps this also tells us there`s nothing currently on the table for investment for a better purpose - Or perhaps it tells us they expect additional revenue, so this expenditure is small potatos in the grand scope of things.

Hope you and yours are doing well - I think I can accurately guess you have a smile on your face today.

Regards

Share
New Message
Please login to post a reply